Nature Communications (Jul 2021)

Lack of consideration of sex and gender in COVID-19 clinical studies

  • Emer Brady,
  • Mathias Wullum Nielsen,
  • Jens Peter Andersen,
  • Sabine Oertelt-Prigione

DOI
https://doi.org/10.1038/s41467-021-24265-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 6

Abstract

Read online

Sex and gender have been associated with differences in SARS-CoV-2 incidence and clinical outcomes and therefore warrant consideration in study designs. Here, the authors assess registered and published clinical COVID-19 studies and find that sex-disaggregated analyses are infrequently presented or planned.